U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H17N5O5S
Molecular Weight 427.434
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SALAZOSULFADIMIDINE

SMILES

CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(C=C2)\N=N\C3=CC(C(O)=O)=C(O)C=C3)=N1

InChI

InChIKey=DFPJEJKMDZFZHC-GHVJWSGMSA-N
InChI=1S/C19H17N5O5S/c1-11-9-12(2)21-19(20-11)24-30(28,29)15-6-3-13(4-7-15)22-23-14-5-8-17(25)16(10-14)18(26)27/h3-10,25H,1-2H3,(H,26,27)(H,20,21,24)/b23-22+

HIDE SMILES / InChI

Description

Salazosulfadimidine is a sulfonamide antibiotic. This drug was studied in patients with chronic inflammatory bowel disease who had developed extraintestinal manifestations when receiving sulfasalazine. Information about the current use of this drug is not available.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.
1982 Apr
Patents

Patents

WO2004026235A2
1
Name Type Language
SALAZOSULFADIMIDINE
INN   MI  
INN  
Official Name English
SALAZOSULFADIMIDINE [MI]
Common Name English
salazosulfadimidine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29739
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C72843
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
INN
991
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
ECHA (EC/EINECS)
219-016-6
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
EPA CompTox
DTXSID10101813
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
EVMPD
SUB10419MIG
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
FDA UNII
W33009B02O
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107040
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
DRUG CENTRAL
3537
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
CAS
2315-08-4
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
SMS_ID
100000080542
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY
MERCK INDEX
m9727
Created by admin on Fri Dec 15 16:02:28 GMT 2023 , Edited by admin on Fri Dec 15 16:02:28 GMT 2023
PRIMARY Merck Index
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966